Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Intervention Study to Assess the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease and Its Impact on Morbidity and Mortality: The ILERVAS Project

NCT03228459 is registered in ClinicalTrials.gov with Institut de Recerca Biomèdica de Lleida as lead sponsor.

NCT NCT03228459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03228459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Intervention Study to Assess the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease and Its Impact on Morbidity and Mortality: The ILERVAS Project
Lead sponsor
Institut de Recerca Biomèdica de Lleida
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 15, 2015
Completion date
December 31, 2028
Enrollment
16,660 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, chronic kidney diseases, metabolic syndrome, prediabetes, subclinical disease and/or syndrome